The role of CD28-mediated signals in T helper cell maturation is not fully understood. We tested the requirement for costimulation through CD28 in several systems of CD4 + T cell differentiation. In vivo priming of mice with genetic disruption of CD28 (CD28 -/-) yielded normal levels of antigen-specific interferon ~/production but markedly diminished levels of interleukin 4 (IL-4) after in vitro restimulation. In response to the pathogenic microbe, Leishmania major, C57BL6 CD28 -/-mice were fully capable of controlling infection and exhibited a normal T helper 1 response. BALB/c CD28 -/-mice unexpectedly exhibited normal susceptibility to L. major. BALB/c CD28 -/-mice developed high levels oflL-4 mRNA and protein induction in the draining lymph nodes. In addition, susceptibility of BALB/c CD28 -/-mice was reversed by neutralization of IL-4 in vivo. We also activated transgenic CD28-bearing T cells from the BALB and C57BL background in vitro in the presence of CTLA4Ig. BALB cells had greater IL-4-producing capacity than C57BL cells in the absence of costimulation. Diverse factors including costimulatory signals, genetic polymorphism, and the nature of the immunogen all influence T helper phenotype commitment, but these results provide evidence that CD28 is not an absolute requirement for generating either Thl or Th2 responses.
U
'nder most circumstances, successful T cell activation requires a signal delivered through the T cell antigen receptor and a second signal referred to as costimulation (1) . T cells activated in vitro in the presence of CD28-B7 blockade display characteristics of anergy (2) , and blockade in vivo has attenuated many T cell-mediated immune responses, including graft rejection (3, 4) and autoimnmnity (5) (6) (7) . Analysis of CD28-deficient mice revealed relatively normal T cell development, preserved cytolytic T cell responses, but impaired B cell help (8) . The role of costimulation in the generation and maintenance of antigen-specific CD4 + T helper (Th) subsets remains controversial. Data supports models in which both Thl and Th2 responses require CD28-mediated signals (2, 9-11), but some evidence suggests that only certain Th subsets are dependent on costimulation (12) (13) (14) (15) (16) (17) (18) (19) (20) . Other findings suggest discrete stages of maturation selectively require CD28-mediated costimulation (12) , and some current models propose that specific B7 ligands mediate biased Th maturation (5, 6, 21, 22) .
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In murine infection with Leishmania major, pathogenspecific CD4 + Th effectors mediate the polarized potential outcomes of infection (23) . Thl responses that arise in C57BL/6 mice result in self-limited heating disease through successful macrophage activation by T cell-derived IFN-y. Th2 responses that arise in mice from the BALB background mediate inexorable susceptibility characterized by uncontrolled parasite dissemination. The unique localization of the parasite to MHC class II-rich intracellular compartments leads to a strong bias in CD4 +, class II-restricted imnmnization, such that polarized anti-leishmanial Thl and Th2 phenotypes proceed normally, even in the genetic absence of MHC class I-restricted responses (24, 24a) . Interventions that reduce the efficiency of CD4 + T cell responses can result in increased susceptibility to infection. Transient suppression of T cell immunity, however, can also yield a default from a Th2 to Thl response with consequent healing in the BALB/c strain (23) .
To address the requirements of CD28-mediated costinaulation in generating Thl and Th2 subset development in vivo, we infected CD28-deficient mice from both C57BL/6 and BALB/c backgrounds with L. major. We also tested antigen-specific cytokine responses to a nonpathogenic antigen, keyhole limpet hemocyanin (KLH). IL-4 and, to a lesser extent, IFN-y production are augmented by CD28-mediated signals. Despite reduced levels of Th cytokine production in vitro, genetically driven polarization of Th responses and stereotyped disease phenotypes were observed in Leishmania-infected, CD28-deficient mice. Transgenic T cells from the BALB and C57BL backgrounds had reduced IL-4 levels when primed in vitro in the presence of CTLA4Ig. Addition of rlL-4 during priming restored IL-4 levels from BALB cells, but not C57BL T cells. Together, these results provide evidence that CD28 is not absolutely required for generating a Th2 response in vivo. Genetic background, the replicating nature of the microbial immunogen, and/or the strength of other second signal activities provided in vivo may overcome the need for a component of activation formerly deemed indispensable for Th cell function.
Materials and Methods

CD28-d~cient
Mice. CD28 -/-mice were generated as described (8) . The animals used in these experiments were from the fifth back-cross to C57BL/6 and fourth or fifth back-cross to BALB/c. Heterozygote and wild-type littermates were used as controls for BALB/c experiments. Commercial wild-type mice (Jackson Laboratories, Bar Harbor, ME) were used as controls for C57BL/6 experiments. Mice were housed in a specific pathogenfree environment. Genotypes were determined by flow cytometry using stains for commercially conjugated fluorescent mAbs against CD28 and CD4 (Caltag Laboratories, South San Francisco, CA) and confirmation by PCR using two oligonucleotide pairs specifically spanning the genomic disruption of CD28 and the neomycin resistance marker. All work was perfomaed in accordance with University of Chicago guidelines for animal use and care.
KLH Immunization. BALB/c CD28 -/-and C57BL/6 CD28 -/ mice plus normal littermate controls were immunized in the hind footpads and base of the tail with 100 txg KLH (CalbiochemNovabiochem Corp., San Diego, CA) emulsified in complete Freund's adjuvant (GIBCO Bt<L, Gaithersburg, MD). 8 d after immunization, draining lymph nodes were harvested and single cell suspensions were prepared in complete DME media (supplemented with 10% FCS, 2-mM t-glutamine, I00 U/ml penicillin, 100 txg/ml streptomycin, 50 ~M 2-ME, 10 m/Vl Hepes, and 100 ~M nonessential amino acids). For the restimulation assay, 5 X 10 s cells were plated in each well of a flat-bottom 96-well microtiter plate (Costar Corp., Cambridge, MA) with either media or KLH at 100 ~g/ml. Supernatants for these and all other experiments were harvested at 48 h and analyzed for IL-4 and IFN-"/by ELISA using commercial mAb pairs (PharMingen, San Diego, CA) according to the manufacturer's instructions.
h!~'ction with L. major. Infections were performed by injection of 5 • 10 ~ metacyclic promastigotes (WHOM/IR/-/173) into each hind footpad. Lesion size was measured weekly with a metric caliper. Select animals were treated with 5 mg n~Ab 11BI 1 (rat IgG1 antiumrine IL-4) intraperitoneally on day 0. Parasite cultures were quantitated by homogenization of tissue in fixed volumes of parasite media. Aliquots were diluted serially across 96-well plates and scored at 1 and 2 wk for parasite growth. Leishmania-infected mice were killed at 6-8 wk after infection and analyzed as individual animals.
Single cell suspensions of popliteal lymph node cells were examined for antigen-specific cytokine production by restimulation in vitro and also for direct ex vivo IL-4 production by ELISPOT. For the restimulation assays, 0. ELISPOTs were performed as previously described (25) using commercial mAb pairs (PharMingen). Briefly, plates were coated with purified antibody, 10 (' lymph node cells were plated in twofold serial dilutions and incubated at 37~ for 4 h. IL-4 spots were detected by sequential addition of biotinylated secondary antibody, streptavidin alkaline phosphatase (Jackson ImnmnoResearch Laboratories Inc., West Grove, PA), followed by development with t mg/ml 5-bromo-4-chloro-3-indolyl phosphate in 0.1 M 2-amino-2-methyl-l-propanol (Sigma Chemical Co., St. Louis, MO) containing 0.6% agarose.
Lymph node cells taken directly from the animal were also placed immediately in RNAzol (Biotecx Laboratories, Houston, TX) and total RNA was extracted according to the manufacturer's instructions, tLNA was reverse transcribed using random hexamer primers (Pharmacia Fine Chemicals, Piscataway, NJ). Semiquantitative PCR was performed as described (26) . Briefly, cDNA was amplified in the presence of a polycolnpetitor construct that contains addition nmtations of the authentic cDNA. Resolved on agarose gels, the larger molecular weight bands provide an internal standard for the relative amounts of the lower molecular weight experimental cDNAs. Concentrations ofcDNAs are adjusted using the housekeeping gene HPRT before assay of lymphokine gene transcription. Results were verified by repetition of both individual samples and whole experiments.
hi vitro Priming qf Trami~enic T Cells. Transgenic D011.10 mice recognizing a chicken ovalbumin-derived (OVA) peptide in the context of GA d were generously provided by Dr. l)ennis Loh (27) . Animals used in these experiments were from the fourth back-cross to B10.D2 or the eighth back-cross to BALB/c. Transgenic mice were identified by flow cytometry using stains for comlnercially conjugated fluorescent mAbs against V [38 and CD4 (Caltag) . Primary cultures were performed in 24-well plates using 5 • 10 s splenocytes from transgenic mice stimulated with 100 ~g/ml of a trypric digest of OVA protein (Sigma). Human CTLA4Ig (20 Ixg/ml; a generous gift from Gary Gray, Repligen Corp., Boston, MA) was used to block B7-mediated costinmlation. After 6 d, cells were washed extensively and counted. Secondary stimulations were replated in 96-well round-bottom plates in triplicate, using 2 X I0 s T cells, 1.2 X 10 ~' irradiated wild-type splenocytes (2,500 rads) as APCs, and 100 Ixg/ml peptide. No cytokine or CTLA4Ig additions were used m secondary cultures. Supernatants were harvested at 48 h and assayed by ELISA. 
Results
CD28-deficient Mice Produce Less Antigen-specific IL-4 after
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lO Impaired Th2 response after in vivo priming of CD28-deficient nfice. C57BL/6 and BALB/c wild-type (+/+) and CD28-deficient ( -/ -) mice were immunized with KLH, as described in Materials and Methods. Draining lymph node cells were restimulated with KLH in vitro, and supernatants were assayed after 48 h for IL-4 and IFN-'y by ELISA. Bars depict the mean values of duplicate wells with the standard deviation expressed as y-axis error bars. Cytokine levels in wells without antigen were below 10 U/ml. Results are representative of four separate experiments, C57BL/6 background and CD28-positive controls were immunized with KLH. In both genetic backgrounds, the absence of CD28 reproducibly resulted in a 10-to 20-fold decrease in IL-4 production upon antigen restimulation of draining lymph node cells compared to their CD28-positive controls (Fig. 1) . In contrast, the levels of I F N -y were similar in both wild-type and CD28-deficient mice of both strains. These results suggested that Th2 responses were more severely impaired than T h l responses. O f particular note, there was profound difference in IL-4 production between BALB/c and C57BL/6 backgrounds, with at least 10-fold greater IL-4 levels in BALB/c animals when matched for CD28 expression. The genetic disparity led to levels of IL-4 production that were comparable between BALB/c CD28 -/-and wild-type C57BL/6 mice.
CD28-deficient C57BL/6 Mice Control Infection with L. major with Normal Th l-Type Responses.
To address the requirement for CD28-mediated signals in microbial i m m unity, we challenged CD28-deficient mice with L. major.
CD28 +/+ and CD28 -/ mice from the resistant C57BL/6 background and susceptible BALB/c mice were infected with L. major promastigotes in the hind footpad and monitored for their response to intbction. C57BL/6 CD28 -/ -mice and C57BL/6 wild-type mice both controlled infection as assessed by footpad lesion size (Fig. 2 A) . Quantitative parasite cultures revealed equivalently low burdens for all C57BL/6 background animals that were approximately five orders of magnitude less in the feet and three orders of magnitude less in the spleens than susceptible BALB/c mice. CD28-deficient mice also displayed normal delayedtype hypersensitivity responses to Leishmania antigens in comparison to wild-type C57BL/6 mice (data not shown).
Analysis of Th cytokine production in infected animals was performed by restimulating single-cell suspensions of popliteal lymph node cells with soluble Leishmania antigens in vitro. Compared to wild-type C57BL/6 mice, CD28 -/ -mice had normal levels of antigen-specific I F N -y production and comparably low levels of antigen-specific IL-4 production (Fig. 2 B) . In addition, cytokine production could be blocked with anti-class II mAbs in culture (Fig. 2 B) , suggesting that conventional class II-restricted Th cells are the source of these cytokines. Analysis of cytokine transcripts taken directly ex vivo from lymph nodes of CD28 -/ also revealed fully mature T h l responses compared to control-resistant mice (Fig. 2 C) . Furthermore, C57BL/6 CD28 -/-mice healed in an I F N -y -d e p e n d e n t fashion, as demonstrated by the ability of a n t i -I F N -y mAb treatment to abrogate resistance in both the CD28-deficient and wild-type controls (data not shown). We conclude that CD28-mediated costinmlation is not required for efficient T h l responses in vivo against this pathogen. (Fig. 3 /3 ). T h e apparent diminution in the strength o f the T h 2 response, h o w e v e r , was only evident in the in vitro restimulation assays. Direct ex vivo analysis o f draining l y m p h node cells by quantitative P C P , revealed normal amounts o f IL-4 transcripts in B A L B / c C D 2 8 -/ mice (Fig. 3 C) . E L I S P O T assays performed directly on l y m p h node cells of infected animals w i t h o u t the use o f antigen restimulation also revealed comparable levels o f IL-4 protein production (Fig. 3 D) . (Fig. 3 D) similar to the results obtained from restimulation assays (Fig. 3/3 ). These data suggest that signals that allow for efficient C D 2 8 -i n d e p e n d e n t Th2 dev e l o p m e n t in vivo cannot always be fully recapitulated in vitro.
CD28-deficient Mice from the BALB/c Background Are Susceptible to L. major Infection and Mount Normal IL-4--dependent
W h i l e the E L I S P O T done immediately upon isolation showed an equivalent n u m b e r o f I L -4 -p r o d u c i n g cells, a second E L I S P O T done after 2 d o f restimulation in vitro demonstrated a difference b e t w e e n the C D 2 8 -/ and w i l d -w p e animals
T parably to treated wild-type BALB/c mice (Fig. 3 E) and to genetically resistant control animals (data not shown). We conclude that CD28-deficient animals can, under some circumstances, mount fully normal Th2 responses in vivo.
Th2 Responses can be Induced in BALB/c-transgenic T Cells in the Absence of Costimulation. Because of the unexpected finding of intact Th2 responses in Leishmania-infected
BALB/c CD28 -/-mice, we examined alternative signals that promote Th2 differentiafon. Using naive transgenic T cells, we assessed the effect of genetic background and cytokine environment on Th2 development when T cell activation was initiated without costimulation. D011.10 TC1K-transgenic mice were bred onto either the H-2 d congenic BALB/c or B10.D2 (C57BL) backgrounds. In these assays, T cells undergo primary activation in the presence of experimental variables such as rIL-4 (to induce Th2 maturation) or CTLA4Ig (to block costimulation). To assess the impact of the initial experimental variables on early T cell activation, cells are restimulated without cytokine or CTLA4Ig addition. For cells from the C57BL background, Th2 maturation was limited by the addition of CTLA4Ig, consistent with published findings (10) . In contrast, BALB T cells underwent nomlal Th2 maturation in the absence ofcostimulation (Fig. 4) . This phenotypic difference between strains parallels and may be under the same genetic control as their tendency toward T helper polarization with no cytokine or CTLA4Ig addition (Fig. 4 and reference 28) .
Discussion
Since the initial description of reciprocally dominant cell-mediated or humoral immune responses to repeated injections of flagellin (29) , it has become increasingly dear that Th responses move toward polarized maturational states. Many factors, including the type of APC, form of antigen, route of immunization, genetic background (28, 30) , and, perhaps most notably, the type of cytokines present during activation, can influence biased differentiation (reviewed in reference 31). In the original study of repetitive immunization (29) , and in more recent studies with transgenic T cells (32, 33) , antigen dose was shown to participate in the regulation of Th lineage commitment. Several recent models of T cell activation have proposed that the strength of signal encompassing both antigen dose and quantity ofcostimulation leads to more Th2-1ike (high stimulation) or Thl-like (low stimulation) outcomes (34, 35) .
Whether there is a requirement for CD28-B7 interaction in Th subset maturation and commitment is still characterized by significant controversy. Early work on T cell clones suggested that costimulation was selectively required for Thl cells. The absence of costimulation resulted in anergy of Thl clones (2) and induced Th0 clones to become Th2-1ike (20) . By contrast, it has recently been shown that costimulation may selectively activate Th2 cells. CD28 ligation makes Th2 clones more responsive to IL-4 (9) and can be a sufficient second signal to drive Th2 development, even in the absence of IL-4 (17, 18) . Similar controversy surrounds data from in vivo model systems. Although in vivo blockade of B7-mediated costimulation has prevented diverse conditions from xenograft (3) and allograft (4) rejection to murine autoimmune diabetes (5), demyelination (6) , and lupus (7), the regulatory mechanisms underlying these effects are still poorly understood. Treatment with CTLA41g caused diminution of Thl response with sparing of Th2 responses in allograft transplantation (15) , but transient blockade effectively abrogated Th2 responses while sparing Thl function in response to an intestinal nematode (16) and L. major (13) .
The current study sought to determine the requirement for CD28 in the generation and maintenance of biased Th responses using several well-characterized models of CD4 + T cell maturation. Previous studies have shown that in vitro priming of transgenic T cells in the presence of CTLA4Ig effectively diminished the ability to prime both Thl and Th2 responses (10) . In addition, in vitro priming of CD28-deficient transgenic T cells can initiate but not sustain primary proliferative responses (11) . In vivo immunization in the presence of CTLA4Ig has led to inefficient clonal expansion (36) and effector function (14) . Together, these and other results predicted that the absence of CD28 might lead to global or selective limitations in the ability to generate normal Th responses. The data presented here, however, provide the first in vivo evidence that CD28 is not an absolute requirement to generate strong Thl or Th2 responses.
In genetically resistant C57BL/6 mice lacking CD28, there was no impairment in the ability to generate IFN-~-secreting Thl-type cells capable of controlling leishmaniasis. This was surprising based on the immunosuppressive capacity of CTLA4Ig in vivo (3, 4) and given the data that Thl clones (2) and lines (12) are more dependent on costimulation. Efficient class lI-restricted IFN-~/ production could be generated in response to both a model antigen and a replicating pathogen. Both at the level ofeffector cytokine production and Th cell expansion (Brown, D., un-published results), Thl responses proceeded normally. This was not unique to the C57BL/6 genetic background, since BALB/c mice infected with L. major and given neutralizing anti-IL-4 antibodies also demonstrated normal healing responses.
The generation of Th2 responses in CD28-deficient mice is perplexing: the finding that early CTLA4Ig administration can prevent Th2 development in response to L. major (13) , together with the findings that CD28 -/-mice have reduced basal levels of IgG1, increased IgG2a and inefficient B cell help (8) might have led to a prediction that costimulation is required for maturation of Th2 responses. In the present study, CD28-deficient mice had decreased IL-4 production in restimulation assays after antigen priming or L. major infection. BALB/c CD28 /-mice, however, generated sufficient IL-4 to mediate susceptibility as demonstrated by the readily-induced resistance of anti-IL-4-treated mice. Direct measurements of IL-4 gene transcription and protein-producing cells from BALB/c CD28 -/-mice actually indicate that their Th2 responses against L. major are fully intact in vivo. The apparent deficiency of IL-4 from in vitro assays may be caused by physical disruption of the cognate architecture required to compensate CD28-mediated signals in vivo, the inability to deliver important soluble factors in the appropriate paracrine fashion, or the inability of CD28-deficient cells to survive (37) or proliferate normally despite normal cytokine production. These findings raise the possibility that many of the biologic properties observed after in vitro manipulation of costinmlation may have limited predictive value for inmmne responses in vivo.
Our data illustrates that genetic factors can influence the need for costimulation. Although there was a general trend toward preserved Thl and impaired Th2 development in CD28-'-mice, variation in genetic background may contribute to phenotype commitment as much as costimulation. In the presence of CTLA4Ig, C57BL transgenic T cells could not be induced to make IL-4 even with the addition of rlL-4 in the primary cultures, consistent with reports using other TC1K-transgenic mice on the C57BL (B10.A) background (10) . in contrast, BALB/c T cells incubated with rlL-4 during primary activation were able to generate IL-4-producing effectors despite the presence of CTLA41g. There was also a background contribution to IL-4 production in response to KLH immunization. BALB/c mice produced 10-fold higher IL-4 than C57BL/6 mice, consistent with reports of others (38) . The BALB/c genetic predisposition resulted in comparable levels of IL-4 between BALB/c CD28 "-and C57BL/6 CD28 +/+ mice. It is unlikely, however, that genetic polymorphism is the sole reason for preserved Th2 responses to L. major challenge, since anti-IFN-3, treatment of C57BL/6 CD28 -/-mice also resulted in increased IL-4 mlKNA (Brown, D., unpublished results). In addition, C57BL/6 CD28 -/-mice are able to mount normal Th2 responses after challenge with an intestinal helminth (Gause, W., personal communication).
BALB/c CD28 -/ mice were able to generate a func- (13) . One potential explanation for this discrepancy is that developmental compensatory mechanisms have endowed CD28-" cells with the capacity to be activated in a manner not possible in CD28-bearing cells. Compensation could be manifest as overproduction of soluble factor(s) or overexpression of surface molecule(s). The current in vitro finding that rlL-4 could correct impaired Th2 differentiation caused by CTLA4Ig might predict that a compensatory increase in autocrine IL-4 production in vivo could overcome the genetic absence of costimulation. Even without invoking compensatory abnormalities, there are significant differences between the infection of BALB/c CD28 -/-mice compared to the treatment of infected BALB/c mice with CTLA4Ig. The transient nature of blockade using CTLA4Ig may allow selective outgrowth of Thl ceils similar to other curative interventions in BALB/c mice that are based on transient reduction in CD4 + T cell responses (23) . Sustained absence of costimulation in CD28 /-mice could favor genetically or microbially driven outgrowth of Th2 responses if maintenance of Th2 responses is less CI)28-dependent than maintenance of Thl responses (2, 12, 20) . This model would be consistent with the finding that either sustained or delayed blockade with CTLA4Ig was far less efficacious than early treatment in L. major-iufected mice (13) . CD28-deficient mice also differ from CTLA4Ig-treated wild-type mice in the extent of blockade. The additional loss of CTLA4-mediated signals in treated mice may have distinct effects on Th development compared to the absence of CD28 alone. Treatment of CD28 J-mice with CTLA4Ig, however, failed to abrogate Th2 responses (Brown, D., unpublished results), consistent with data that T cell activation in CD28-deficient mice is not B7-dependent (41) . The maturation of Th precursors into biased Thl or Th2 subsets is affected by numerous factors. The present results demonstrate that CD28 is not an absolute requirement for generating either of the polarized subsets. BALB/c-transgenic T cells activated in the presence of rlL-4 can be primed to become Th2 cells in the absence of costimulation through CD28. Conversely, studies with human T ceils have demonstrated an ability to generate Th2 cells despite neutralization of IL-4 if CD28-mediated costimulation was provided (17, 18) . Together, these findings support a complex model of Th maturation in which there are distinct sufficient signals for Th2 development rendering no signal an absolute necessity depending on the presence of the other determinants. Thl clones can also be cooperatively costimulated by B7 and rlL-12 (42) . This finding, together with recent descriptions of novel Thl costimulatory molecules (43) and Thl-inducing cytokines (44) , suggests similar redundancy in the Thl pathways. Models of Th cell differentiation will need to account for the complexity of factors that influence polarized Th responses.
